At the beginning of the 20th century, Santiago Ramón y Cajal, regarded as the father of modern neuroscience, proposed a theory that adult brain cells are static, finite, and immutable, suggesting that once neurons die, they can never regenerate. This long-held belief dominated the understanding of the brain until recent decades when researchers began to challenge this notion, focusing on neurogenesis—the process of creating new neurons in adult humans. The central questions raised by researchers are whether this process truly occurs, how frequently it happens, and its efficacy in combating neurological diseases such as Alzheimer's.

Initial evidence indicating that neurogenesis may occur was found as early as 1962 when Josef Altman from the Massachusetts Institute of Technology questioned Cajal's views. He demonstrated through radioactive labeling that new neurons can form in adult rats, especially in the hippocampus, which plays a key role in learning and memory. Despite this, many experts remained skeptical, primarily seeking further validation of similar processes in human brains and the implications for age-related cognitive decline.

The ongoing research into the brains of seniors is pivotal as it challenges the narratives that long dictated our understanding of cognitive aging. If further studies continue to support the presence and impact of neurogenesis in older adults, it could revolutionize treatments for Alzheimer's disease and potentially allow for the development of therapies that enhance cognitive function, reduce memory loss, and foster overall brain health in aging populations.